Skip to main content

Closed

RDHL: RedHill Biopharma Ltd. Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

1thpctl

Volume

0.06×avg

Market Cap

2.04MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

RedHill Biopharma Ltd.

RDHLNASDAQ Global Market·USD·Closed

RedHill Biopharma Ltd.

RDHLNASDAQ·USD·Closed

$0.65

+3.06%

$0.65

+$0.02 (3.06%)

52W Range

1thpctl

Volume

0.06×avg

Mkt Cap

2.04MUSD

P/E

-0.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings